Home LiteratureArticle Details
PMID: 18073786 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Biologically based modeling of multimedia, multipathway, multiroute population exposures to arsenic.

Journal of exposure science & environmental epidemiology ·Vol. 18 ·No. 5 ·2008-09-00 ·Pages 462-76

Georgopoulos PG, Wang SW, Yang YC, Xue J, Zartarian VG, McCurdy T, Ozkaynak H

Abstract

This article presents an integrated, biologically based, source-to-dose assessment framework for modeling multimedia/multipathway/multiroute exposures to arsenic. Case studies demonstrating this framework are presented for three US counties (Hunderton County, NJ; Pima County, AZ; and Franklin County, OH), representing substantially different conditions of exposure. The approach taken utilizes the Modeling ENvironment for TOtal Risk studies (MENTOR) in an implementation that incorporates and extends the approach pioneered by Stochastic Human Exposure and Dose Simulation (SHEDS), in conjunction with a number of available databases, including NATA, NHEXAS, CSFII, and CHAD, and extends modeling techniques that have been developed in recent years. Model results indicate that, in most cases, the food intake pathway is the dominant contributor to total exposure and dose to arsenic. Model predictions are evaluated qualitatively by comparing distributions of predicted total arsenic amounts in urine with those derived using biomarker measurements from the NHEXAS--Region V study: the population distributions of urinary total arsenic levels calculated through MENTOR and from the NHEXAS measurements are in general qualitative agreement. Observed differences are due to various factors, such as interindividual variation in arsenic metabolism in humans, that are not fully accounted for in the current model implementation but can be incorporated in the future, in the open framework of MENTOR. The present study demonstrates that integrated source-to-dose modeling for arsenic can not only provide estimates of the relative contributions of multipathway exposure routes to the total exposure estimates, but can also estimate internal target tissue doses for speciated organic and inorganic arsenic, which can eventually be used to improve evaluation of health risks associated with exposures to arsenic from multiple sources, routes, and pathways.

MeSH Terms
Arsenic/pharmacokinetics,urine Biomarkers/urine Databases, Factual Diet Drinking Environmental Exposure/analysis Environmental Monitoring/methods Female Food Contamination/analysis Humans Inhalation Exposure/analysis Male Models, Biological Risk Assessment/methods United States Water/chemistry Water Pollutants/analysis
Chemicals
Biomarkers Water Pollutants Water Arsenic
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Georgopoulos Panos G
Environmental and Occupational Health Sciences Institute (EOHSI), A Joint Institute of UMDNJ--R.W. Johnson Medical School and Rutgers University, 170 Frelinghuysen Road, Piscataway, New Jersey 08854, USA. [email protected]
Wang Sheng-Wei
Yang Yu-Ching
Xue Jianping
Zartarian Valerie G
McCurdy Thomas
Ozkaynak Halûk
References (33)
33 references, click to expand
  1. A market basket survey of inorganic arsenic in food.
    Food Chem Toxicol. 1999 Aug;37(8):839-46 PMID: 10506007
  2. FDA Total Diet Study, July 1986-April 1991, dietary intakes of pesticides, selected elements, and other chemicals.
    J AOAC Int. 1995 Nov-Dec;78(6):1353-63 PMID: 8664570
  3. A modeling framework for estimating children's residential exposure and dose to chlorpyrifos via dermal residue contact and nondietary ingestion.
    Environ Health Perspect. 2000 Jun;108(6):505-14 PMID: 10856023
  4. A probabilistic arsenic exposure assessment for children who contact chromated copper arsenate (CCA)-treated playsets and decks, Part 2: Sensitivity and uncertainty analyses.
    Risk Anal. 2006 Apr;26(2):533-41 PMID: 16573638
  5. Development of a human physiologically based pharmacokinetic (PBPK) model for inorganic arsenic and its mono- and di-methylated metabolites.
    J Pharmacokinet Pharmacodyn. 2008 Feb;35(1):31-68 PMID: 17943421
  6. A population exposure model for particulate matter: case study results for PM(2.5) in Philadelphia, PA.
    J Expo Anal Environ Epidemiol. 2001 Nov-Dec;11(6):470-89 PMID: 11791164
  7. In vivo and in vitro percutaneous absorption and skin decontamination of arsenic from water and soil.
    Fundam Appl Toxicol. 1993 Apr;20(3):336-40 PMID: 8504907
  8. Comparison of the urinary excretion of arsenic metabolites after a single oral dose of sodium arsenite, monomethylarsonate, or dimethylarsinate in man.
    Int Arch Occup Environ Health. 1981;48(1):71-9 PMID: 6894292
  9. The national exposure research laboratory's consolidated human activity database.
    J Expo Anal Environ Epidemiol. 2000 Nov-Dec;10(6 Pt 1):566-78 PMID: 11140440
  10. Assessing the measurement precision of various arsenic forms and arsenic exposure in the National Human Exposure Assessment Survey (NHEXAS).
    Environ Health Perspect. 2006 Feb;114(2):220-7 PMID: 16451858
  11. A physiologically based pharmacokinetic model for arsenic exposure. II. Validation and application in humans.
    Toxicol Appl Pharmacol. 1996 Oct;140(2):471-86 PMID: 8887465
  12. A probabilistic arsenic exposure assessment for children who contact CCA-treated playsets and decks, Part 1: Model methodology, variability results, and model evaluation.
    Risk Anal. 2006 Apr;26(2):515-31 PMID: 16573637
  13. A source-to-dose assessment of population exposures to fine PM and ozone in Philadelphia, PA, during a summer 1999 episode.
    J Expo Anal Environ Epidemiol. 2005 Sep;15(5):439-57 PMID: 15714222
  14. A physiologically based pharmacokinetic model of inorganic arsenic.
    Regul Toxicol Pharmacol. 1999 Apr;29(2 Pt 1):128-41 PMID: 10341143
  15. Modeled estimates of chlorpyrifos exposure and dose for the Minnesota and Arizona NHEXAS populations.
    J Expo Anal Environ Epidemiol. 2001 May-Jun;11(3):253-68 PMID: 11477522
  16. Urinary trivalent methylated arsenic species in a population chronically exposed to inorganic arsenic.
    Environ Health Perspect. 2005 Mar;113(3):250-4 PMID: 15743710
  17. Estimation of the dietary intake of cadmium, lead, mercury, and arsenic by the population of Santiago (Chile) using a Total Diet Study.
    Food Chem Toxicol. 2005 Nov;43(11):1647-55 PMID: 15975702
  18. Excretion of arsenic in urine as a function of exposure to arsenic in drinking water.
    Environ Health Perspect. 1999 Aug;107(8):663-7 PMID: 10417365
  19. Arsenic and cigarette smoke synergistically increase DNA oxidation in the lung.
    Toxicol Pathol. 2006;34(4):396-404 PMID: 16844668
  20. The cellular metabolism and systemic toxicity of arsenic.
    Toxicol Appl Pharmacol. 2001 Oct 15;176(2):127-44 PMID: 11601889
  21. A pharmacokinetic modeling of inorganic arsenic: a short-term oral exposure model for humans.
    Chemosphere. 1999 Dec;39(15):2737-47 PMID: 10633549
  22. Dietary arsenic intakes in the United States: FDA Total Diet Study, September 1991-December 1996.
    Food Addit Contam. 1999 Nov;16(11):465-72 PMID: 10755138
  23. Human retention studies with 74As.
    Toxicol Appl Pharmacol. 1980 May;53(3):550-6 PMID: 7385250
  24. Percutaneous absorption of arsenic from environmental media.
    Toxicol Ind Health. 2005 Mar;21(1-2):1-14 PMID: 15986571
  25. Use of human metabolic studies and urinary arsenic speciation in assessing arsenic exposure.
    Bull Environ Contam Toxicol. 1991 Jan;46(1):53-61 PMID: 2001493
  26. Population-based dietary intakes and tap water concentrations for selected elements in the EPA region V National Human Exposure Assessment Survey (NHEXAS).
    J Expo Anal Environ Epidemiol. 1999 Sep-Oct;9(5):402-13 PMID: 10554143
  27. Dietary intakes of pesticides, selected elements, and other chemicals: FDA Total Diet Study, June 1984-April 1986.
    J AOAC Int. 1995 Jul-Aug;78(4):910-21 PMID: 7580329
  28. Elucidating the pathway for arsenic methylation.
    Toxicol Appl Pharmacol. 2004 Aug 1;198(3):319-26 PMID: 15276411
  29. Assessment of human exposure to copper: a case study using the NHEXAS database.
    J Expo Sci Environ Epidemiol. 2006 Sep;16(5):397-409 PMID: 16249795
  30. Developmentally restricted genetic determinants of human arsenic metabolism: association between urinary methylated arsenic and CYT19 polymorphisms in children.
    Environ Health Perspect. 2005 Jun;113(6):775-81 PMID: 15929903
  31. Environmental, dietary, demographic, and activity variables associated with biomarkers of exposure for benzene and lead.
    J Expo Anal Environ Epidemiol. 2003 Nov;13(6):417-26 PMID: 14603342
  32. Survey of arsenic in total diet food composites and estimation of the dietary intake of arsenic by Canadian adults and children.
    J AOAC Int. 1993 Jan-Feb;76(1):14-25 PMID: 8448438
  33. From a theoretical framework of human exposure and dose assessment to computational system implementation: the Modeling ENvironment for TOtal Risk Studies (MENTOR).
    J Toxicol Environ Health B Crit Rev. 2006 Nov-Dec;9(6):457-83 PMID: 17090483
Article Info
Journal
Journal of exposure science & environmental epidemiology
Abbr.
J Expo Sci Environ Epidemiol
ISSN
1559-064X
Published
2008-09-00
Epub
2007-00-12
Pages
462-76
Language
English
Region
United States
NLM ID
101262796
PMCID
PMC3068596
Subset
IM
Grants
NIEHS NIH HHS · P30 ES005022 · United States
NIEHS NIH HHS · P30 ES005022-22 · United States
NIEHS NIH HHS · P30ES005022 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]